569 filings
Page 3 of 29
3
zp0agc9 skbos6qvax
26 Dec 23
Neurogene / ROBERT BAFFI ownership change
6:10pm
3
g7xz0b
26 Dec 23
Neurogene / Stuart Cobb ownership change
6:05pm
3
1yp4msax3jo04vu11nh
26 Dec 23
Neurogene / Cory S. Freedland ownership change
6:04pm
SC 13G/A
oroppt ix
22 Dec 23
Neurogene / Redmile ownership change
4:15pm
SC 13D
1avnz2b47b
21 Dec 23
Neurogene / McMinn Rachel ownership change
4:05pm
4
5wfbavj ls
20 Dec 23
Neurogene / JULIAN BAKER ownership change
6:43pm
SC 13D/A
e7nbb e72x6vnkq9
20 Dec 23
Neurogene / BAKER BROS. ADVISORS ownership change
5:24pm
8-K
majdeamwt7dmm diyyqu
19 Dec 23
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
7:31am
425
3tmy 66cfxf
6 Dec 23
Business combination disclosure
4:24pm
8-K
rw33r4 aj
6 Dec 23
Other Events
4:21pm
425
q784mbpq
4 Dec 23
Business combination disclosure
5:14pm
8-K
wcjjtjuc
4 Dec 23
Other Events
5:10pm
425
t115bjg0
30 Nov 23
Business combination disclosure
4:06pm
EFFECT
wu9q jlsawim
14 Nov 23
Notice of effectiveness
12:15am
SEC STAFF LETTER
qyws8 qwh
13 Nov 23
SEC staff letter
12:00am
CORRESP
g8o rjayhjl
8 Nov 23
Correspondence with SEC
12:00am
CORRESP
5lqd3r5
8 Nov 23
Correspondence with SEC
12:00am